Search results
Results From The WOW.Com Content Network
Since 2006, the Tōkaidō Shinkansen's ATC-1A system has been superseded by ATC-NS. ATC-2: Used on the Tōhoku, Jōetsu and Nagano Shinkansen routes, it utilized 0, 30, 70, 110, 160, 210 and 240 km/h (0, 19, 43, 68, 99, 130 and 149 mph) trackside speed limits. In recent years, ATC-2 has been superseded by the digital DS-ATC.
The predecessor for the Tokaido and Sanyo Shinkansen lines was originally conceived at the end of the 1930s as a 1,435 mm (4 ft 8 + 1 ⁄ 2 in) standard gauge dangan ressha (bullet train) between Tokyo and Shimonoseki, which would have taken nine hours to cover the nearly 1,000-kilometer (620 mi) distance between the two cities.
Dasotraline (INN; [1] former developmental code name SEP-225,289) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that was under development by Sunovion for the treatment of attention-deficit hyperactivity disorder (ADHD) and binge eating disorder (BED).
The Intercity Nieuwe Generatie (transl. Intercity New Generation), or ICNG, nicknamed "Wesp" (Wasp) is an electric multiple unit trainset of the Dutch Railways.In addition to supplementing the existing intercity rolling stock, it will replace the Bombardier TRAXX locomotives and Intercityrijtuig [] coaches on the high-speed line between Amsterdam and Belgium.
As of December 2022, OPC-64005 is in phase 2 clinical trials for major depressive disorder. [1] [2] It reached phase 2 clinical trials for ADHD prior to the discontinuation of its development for this use. [1] It completed a phase 2 clinical trial for ADHD comparing it with placebo and atomoxetine, but the results of this trial were not ...
In 2022, civil air transportation contributed $1.8 trillion in U.S. economic activity, supported 9.4 million jobs, and made up 4 percent of the U.S. gross domestic product. [19] NextGen delivers benefits to continue to support U.S. aviation. [20] Air traffic controllers have better information to track and separate aircraft safely and ...
Chlorosipentramine is an analogue of the anorectic drug sibutramine, which has been sold as an ingredient in weight loss products sold as dietary supplements, first detected in South Korea in 2017. [1]
Viloxazine is indicated to treat attention deficit hyperactivity disorder (ADHD) in children age 6 to 12 years, adolescents age 13 to 17 years, and adults. [1]Analyses of clinical trial data suggest that viloxazine produces moderate reductions in symptoms; it is about as effective as atomoxetine and methylphenidate but with fewer side effects.